Belite Bio, Inc

Belite Bio, Inc Beats on EPS, Stock Up 0.76%

Belite Bio, Inc reported a narrower loss than expected, which resulted in a positive stock reaction, with shares rising by 0.76%. However, there was no revenue reported, and no guidance was provided for future performance. Investors may be cautiously optimistic about the EPS surprise, but the lack of revenue and guidance leaves uncertainty about the company's growth prospects.